 Duncan Wilcox
Concepts (543)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 27 | 2024 | 175 | 5.100 |
Why?
| | Cloaca | 18 | 2023 | 49 | 3.650 |
Why?
| | Urologic Surgical Procedures | 18 | 2024 | 106 | 3.020 |
Why?
| | Hypospadias | 7 | 2022 | 28 | 2.880 |
Why?
| | Urinary Bladder Neck Obstruction | 5 | 2023 | 21 | 2.330 |
Why?
| | Urogenital Abnormalities | 10 | 2023 | 52 | 2.300 |
Why?
| | Anorectal Malformations | 10 | 2024 | 112 | 1.940 |
Why?
| | Urinary Bladder, Neurogenic | 6 | 2024 | 35 | 1.940 |
Why?
| | Urethra | 11 | 2020 | 52 | 1.880 |
Why?
| | Lower Urinary Tract Symptoms | 6 | 2024 | 54 | 1.830 |
Why?
| | Urodynamics | 6 | 2024 | 34 | 1.650 |
Why?
| | Hydronephrosis | 7 | 2015 | 34 | 1.640 |
Why?
| | Urology | 8 | 2024 | 58 | 1.500 |
Why?
| | Urogenital System | 4 | 2023 | 17 | 1.480 |
Why?
| | Ureteral Obstruction | 5 | 2022 | 59 | 1.340 |
Why?
| | Urinary Bladder, Overactive | 2 | 2021 | 20 | 1.310 |
Why?
| | Spinal Dysraphism | 6 | 2017 | 67 | 1.240 |
Why?
| | Kidney | 13 | 2023 | 1305 | 1.130 |
Why?
| | Circumcision, Male | 2 | 2019 | 14 | 1.090 |
Why?
| | Postoperative Complications | 20 | 2024 | 2479 | 1.070 |
Why?
| | Hirschsprung Disease | 9 | 2024 | 101 | 1.060 |
Why?
| | Lactams, Macrocyclic | 2 | 2017 | 49 | 1.050 |
Why?
| | Benzoquinones | 2 | 2017 | 47 | 1.050 |
Why?
| | Urologic Surgical Procedures, Male | 3 | 2022 | 29 | 1.050 |
Why?
| | Urinary Tract | 5 | 2016 | 37 | 1.040 |
Why?
| | Infant | 50 | 2024 | 8913 | 1.030 |
Why?
| | Hernias, Diaphragmatic, Congenital | 15 | 1998 | 204 | 0.970 |
Why?
| | Pain, Postoperative | 4 | 2020 | 224 | 0.960 |
Why?
| | Hernia, Diaphragmatic | 13 | 2000 | 69 | 0.930 |
Why?
| | Urinary Incontinence | 6 | 2015 | 63 | 0.920 |
Why?
| | Child | 64 | 2024 | 20721 | 0.900 |
Why?
| | Reoperation | 11 | 2018 | 550 | 0.870 |
Why?
| | Male | 93 | 2024 | 62883 | 0.860 |
Why?
| | Tocotrienols | 1 | 2023 | 3 | 0.840 |
Why?
| | Cryptorchidism | 5 | 2024 | 12 | 0.840 |
Why?
| | Child, Preschool | 44 | 2024 | 10373 | 0.840 |
Why?
| | Urination | 4 | 2022 | 44 | 0.840 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 231 | 0.840 |
Why?
| | Urologic Diseases | 5 | 2018 | 38 | 0.830 |
Why?
| | Ureter | 6 | 2019 | 35 | 0.820 |
Why?
| | Postoperative Care | 3 | 2019 | 243 | 0.790 |
Why?
| | Rectum | 7 | 2023 | 169 | 0.790 |
Why?
| | Muscle, Smooth | 4 | 2017 | 145 | 0.780 |
Why?
| | Humans | 144 | 2024 | 128524 | 0.780 |
Why?
| | Penis | 3 | 2019 | 36 | 0.770 |
Why?
| | Urinary Bladder Diseases | 4 | 2022 | 18 | 0.760 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 39 | 0.740 |
Why?
| | Kidney Pelvis | 4 | 2022 | 24 | 0.730 |
Why?
| | Anger | 1 | 2021 | 56 | 0.730 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2021 | 20 | 0.720 |
Why?
| | Anal Canal | 6 | 2023 | 89 | 0.710 |
Why?
| | Cystostomy | 3 | 2017 | 9 | 0.710 |
Why?
| | TRPV Cation Channels | 1 | 2021 | 34 | 0.710 |
Why?
| | Calcium Channels | 1 | 2021 | 152 | 0.670 |
Why?
| | Female | 87 | 2024 | 68127 | 0.670 |
Why?
| | Constipation | 1 | 2021 | 89 | 0.660 |
Why?
| | Retrospective Studies | 45 | 2024 | 14460 | 0.650 |
Why?
| | Ultrasonography, Prenatal | 8 | 2014 | 266 | 0.640 |
Why?
| | Follow-Up Studies | 23 | 2018 | 4898 | 0.630 |
Why?
| | Laparoscopy | 7 | 2024 | 454 | 0.630 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2018 | 3 | 0.620 |
Why?
| | Cholinergic Fibers | 1 | 2018 | 17 | 0.610 |
Why?
| | Receptors, Muscarinic | 1 | 2018 | 18 | 0.610 |
Why?
| | Photography | 1 | 2019 | 98 | 0.610 |
Why?
| | Intestine, Large | 1 | 2018 | 13 | 0.600 |
Why?
| | Genitalia, Female | 2 | 2018 | 38 | 0.600 |
Why?
| | Muscle Contraction | 3 | 2019 | 421 | 0.590 |
Why?
| | Vesico-Ureteral Reflux | 4 | 2012 | 26 | 0.590 |
Why?
| | Fecal Incontinence | 6 | 2018 | 80 | 0.570 |
Why?
| | Anesthetics, Local | 2 | 2015 | 76 | 0.570 |
Why?
| | Preoperative Care | 3 | 2011 | 342 | 0.560 |
Why?
| | Urination Disorders | 2 | 2015 | 13 | 0.560 |
Why?
| | Vagina | 3 | 2023 | 175 | 0.560 |
Why?
| | Perioperative Care | 2 | 2018 | 149 | 0.550 |
Why?
| | Pulmonary Surfactants | 9 | 2000 | 106 | 0.550 |
Why?
| | Treatment Outcome | 23 | 2022 | 10163 | 0.530 |
Why?
| | Bladder Exstrophy | 6 | 2007 | 16 | 0.520 |
Why?
| | Clitoris | 1 | 2016 | 9 | 0.510 |
Why?
| | Infant, Newborn | 28 | 2020 | 5687 | 0.500 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2015 | 3 | 0.490 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2011 | 37 | 0.470 |
Why?
| | Nephrectomy | 5 | 2009 | 159 | 0.460 |
Why?
| | Gastrointestinal Diseases | 1 | 2016 | 197 | 0.450 |
Why?
| | Vincristine | 3 | 2024 | 110 | 0.450 |
Why?
| | Infusion Pumps | 1 | 2013 | 31 | 0.440 |
Why?
| | Colon | 4 | 2023 | 251 | 0.440 |
Why?
| | Recovery of Function | 1 | 2018 | 643 | 0.440 |
Why?
| | Prospective Studies | 14 | 2023 | 7043 | 0.420 |
Why?
| | Animals | 30 | 2024 | 34501 | 0.420 |
Why?
| | Creatinine | 1 | 2015 | 475 | 0.420 |
Why?
| | Pediatrics | 4 | 2024 | 1061 | 0.420 |
Why?
| | Enema | 2 | 2006 | 44 | 0.410 |
Why?
| | Paraphimosis | 1 | 2012 | 1 | 0.410 |
Why?
| | Abnormalities, Multiple | 5 | 2006 | 178 | 0.400 |
Why?
| | Cadherins | 1 | 2014 | 186 | 0.400 |
Why?
| | Bandages | 1 | 2012 | 34 | 0.400 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 257 | 0.390 |
Why?
| | Diagnostic Techniques, Urological | 1 | 2012 | 5 | 0.390 |
Why?
| | Adolescent | 39 | 2024 | 20213 | 0.390 |
Why?
| | Radioisotope Renography | 1 | 2011 | 4 | 0.380 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 903 | 0.380 |
Why?
| | Incidence | 7 | 2024 | 2619 | 0.380 |
Why?
| | Edema | 1 | 2012 | 125 | 0.370 |
Why?
| | Age Factors | 9 | 2019 | 3117 | 0.370 |
Why?
| | Surgical Sponges | 1 | 2011 | 4 | 0.370 |
Why?
| | Guideline Adherence | 1 | 2015 | 525 | 0.360 |
Why?
| | Dissection | 1 | 2011 | 56 | 0.360 |
Why?
| | Stents | 1 | 2014 | 504 | 0.350 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5257 | 0.340 |
Why?
| | Registries | 1 | 2018 | 1878 | 0.340 |
Why?
| | Transition to Adult Care | 2 | 2023 | 75 | 0.340 |
Why?
| | Disease Models, Animal | 10 | 2018 | 3943 | 0.330 |
Why?
| | Fetal Diseases | 3 | 2007 | 148 | 0.330 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 564 | 0.330 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 168 | 0.320 |
Why?
| | Sexual Dysfunction, Physiological | 2 | 2009 | 67 | 0.320 |
Why?
| | Prenatal Diagnosis | 6 | 2007 | 189 | 0.320 |
Why?
| | Wilms Tumor | 3 | 2017 | 77 | 0.320 |
Why?
| | Cystitis | 1 | 2009 | 22 | 0.320 |
Why?
| | Urethral Diseases | 3 | 2020 | 19 | 0.310 |
Why?
| | Mice | 13 | 2024 | 16579 | 0.310 |
Why?
| | Doxorubicin | 2 | 2021 | 322 | 0.310 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2011 | 501 | 0.300 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 281 | 0.300 |
Why?
| | Signal Transduction | 2 | 2021 | 4829 | 0.300 |
Why?
| | Ileum | 2 | 2006 | 115 | 0.290 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2005 | 37 | 0.290 |
Why?
| | Ureterocele | 1 | 2007 | 7 | 0.290 |
Why?
| | Digestive System Abnormalities | 2 | 2004 | 14 | 0.290 |
Why?
| | Pulmonary Gas Exchange | 4 | 1998 | 117 | 0.290 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 110 | 0.290 |
Why?
| | Colon, Sigmoid | 5 | 2021 | 19 | 0.270 |
Why?
| | Urography | 1 | 2006 | 15 | 0.270 |
Why?
| | Cathartics | 1 | 2006 | 15 | 0.270 |
Why?
| | Urinary Bladder Fistula | 2 | 2022 | 10 | 0.270 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 73 | 0.260 |
Why?
| | Vesicovaginal Fistula | 1 | 2005 | 3 | 0.250 |
Why?
| | Kidney Function Tests | 4 | 2015 | 145 | 0.240 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 753 | 0.240 |
Why?
| | Animals, Newborn | 6 | 2018 | 805 | 0.240 |
Why?
| | Pain Measurement | 3 | 2015 | 485 | 0.240 |
Why?
| | Hemorrhage | 1 | 2009 | 644 | 0.230 |
Why?
| | Kidney Neoplasms | 2 | 2009 | 349 | 0.230 |
Why?
| | Postnatal Care | 2 | 2015 | 71 | 0.230 |
Why?
| | Orchiopexy | 2 | 2024 | 5 | 0.230 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2004 | 54 | 0.230 |
Why?
| | Mass Screening | 1 | 2012 | 1152 | 0.220 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 11 | 0.220 |
Why?
| | Endometriosis | 1 | 2024 | 48 | 0.220 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2022 | 123 | 0.220 |
Why?
| | Urinary Diversion | 4 | 2015 | 12 | 0.210 |
Why?
| | Fetus | 1 | 2007 | 758 | 0.210 |
Why?
| | Prognosis | 5 | 2018 | 3780 | 0.210 |
Why?
| | Propensity Score | 1 | 2024 | 261 | 0.210 |
Why?
| | Imaging, Three-Dimensional | 1 | 2006 | 534 | 0.200 |
Why?
| | Delphi Technique | 1 | 2024 | 220 | 0.200 |
Why?
| | Length of Stay | 5 | 2023 | 1121 | 0.200 |
Why?
| | Lung | 6 | 1998 | 3741 | 0.200 |
Why?
| | Sacrum | 1 | 2003 | 75 | 0.200 |
Why?
| | Ultrasonography | 4 | 2015 | 723 | 0.200 |
Why?
| | Risk Assessment | 6 | 2024 | 3256 | 0.200 |
Why?
| | Muscle Development | 1 | 2003 | 103 | 0.200 |
Why?
| | Surgical Flaps | 1 | 2003 | 145 | 0.190 |
Why?
| | Kidney Calices | 1 | 2001 | 1 | 0.190 |
Why?
| | Analgesia | 2 | 2020 | 92 | 0.190 |
Why?
| | Consensus | 2 | 2024 | 633 | 0.190 |
Why?
| | Cell Hypoxia | 3 | 2014 | 229 | 0.190 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 141 | 0.190 |
Why?
| | Sheep | 11 | 1998 | 827 | 0.190 |
Why?
| | Digestive System Surgical Procedures | 2 | 2019 | 98 | 0.190 |
Why?
| | Catheterization | 3 | 2013 | 167 | 0.180 |
Why?
| | Sex Factors | 5 | 2024 | 1949 | 0.180 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 343 | 0.180 |
Why?
| | Testicular Neoplasms | 2 | 2019 | 102 | 0.180 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2020 | 11 | 0.180 |
Why?
| | Pregnancy Outcome | 2 | 2022 | 383 | 0.180 |
Why?
| | Administration, Oral | 1 | 2023 | 757 | 0.180 |
Why?
| | Robotics | 1 | 2022 | 89 | 0.170 |
Why?
| | Gastrostomy | 2 | 1999 | 112 | 0.170 |
Why?
| | Hydrocephalus | 2 | 2011 | 107 | 0.170 |
Why?
| | Colitis, Ulcerative | 2 | 2021 | 114 | 0.170 |
Why?
| | Intestinal Obstruction | 3 | 1997 | 48 | 0.170 |
Why?
| | Prune Belly Syndrome | 2 | 2011 | 7 | 0.170 |
Why?
| | Cell Division | 1 | 2002 | 779 | 0.170 |
Why?
| | Perinatology | 1 | 1999 | 9 | 0.170 |
Why?
| | Hypertrophy | 2 | 2019 | 114 | 0.160 |
Why?
| | Smooth Muscle Myosins | 1 | 2019 | 7 | 0.160 |
Why?
| | Muscle Relaxation | 1 | 2019 | 18 | 0.160 |
Why?
| | Reflex | 2 | 2018 | 68 | 0.160 |
Why?
| | Myosin Light Chains | 1 | 2019 | 27 | 0.160 |
Why?
| | Atlases as Topic | 1 | 2019 | 10 | 0.160 |
Why?
| | Nephrostomy, Percutaneous | 1 | 1999 | 9 | 0.160 |
Why?
| | Emotions | 1 | 2024 | 533 | 0.160 |
Why?
| | Nephrology Nursing | 1 | 2019 | 14 | 0.160 |
Why?
| | Nephrology | 1 | 1999 | 60 | 0.160 |
Why?
| | Pediatric Nursing | 1 | 2019 | 40 | 0.160 |
Why?
| | Diet | 1 | 2006 | 1200 | 0.150 |
Why?
| | Anxiety, Separation | 1 | 2018 | 16 | 0.150 |
Why?
| | Extracellular Matrix | 1 | 2003 | 497 | 0.150 |
Why?
| | Umbilicus | 1 | 1998 | 16 | 0.150 |
Why?
| | Maternal Deprivation | 1 | 2018 | 16 | 0.150 |
Why?
| | Twins, Conjoined | 1 | 1998 | 6 | 0.150 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 120 | 0.150 |
Why?
| | Phospholipids | 2 | 1997 | 209 | 0.150 |
Why?
| | Diagnostic Errors | 1 | 2019 | 160 | 0.150 |
Why?
| | Kidney Diseases | 4 | 2009 | 368 | 0.150 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 681 | 0.150 |
Why?
| | Pilot Projects | 2 | 2023 | 1558 | 0.150 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 1997 | 9 | 0.150 |
Why?
| | Reference Values | 2 | 2018 | 780 | 0.150 |
Why?
| | Medical Errors | 1 | 2019 | 103 | 0.150 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 147 | 0.150 |
Why?
| | Phosphatidylcholines | 2 | 1997 | 146 | 0.140 |
Why?
| | Urinary Catheterization | 2 | 2001 | 24 | 0.140 |
Why?
| | Time Factors | 6 | 2019 | 6503 | 0.140 |
Why?
| | Genitalia, Male | 1 | 1997 | 11 | 0.140 |
Why?
| | Genitalia | 3 | 2019 | 30 | 0.140 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 25 | 0.140 |
Why?
| | Decision Making | 1 | 2024 | 850 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2020 | 3326 | 0.140 |
Why?
| | Informed Consent | 1 | 1998 | 174 | 0.140 |
Why?
| | Adult | 17 | 2024 | 35315 | 0.140 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1997 | 4 | 0.140 |
Why?
| | Peptic Ulcer Hemorrhage | 1 | 1997 | 5 | 0.140 |
Why?
| | Peptic Ulcer Perforation | 1 | 1997 | 4 | 0.140 |
Why?
| | Duodenal Ulcer | 1 | 1997 | 11 | 0.140 |
Why?
| | Caregivers | 1 | 2024 | 807 | 0.140 |
Why?
| | Cholelithiasis | 1 | 1997 | 35 | 0.140 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 260 | 0.140 |
Why?
| | Gallstones | 1 | 1997 | 31 | 0.140 |
Why?
| | Algorithms | 3 | 2018 | 1616 | 0.140 |
Why?
| | Postoperative Period | 1 | 2018 | 322 | 0.130 |
Why?
| | Cancer Survivors | 1 | 2021 | 263 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 774 | 0.130 |
Why?
| | Young Adult | 9 | 2024 | 12320 | 0.130 |
Why?
| | Vulva | 1 | 2016 | 23 | 0.130 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1687 | 0.130 |
Why?
| | Endoscopy | 1 | 1998 | 267 | 0.130 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2017 | 226 | 0.130 |
Why?
| | Patient Safety | 1 | 2019 | 290 | 0.130 |
Why?
| | Fluorocarbons | 1 | 1997 | 109 | 0.120 |
Why?
| | Pregnancy | 11 | 2022 | 6297 | 0.120 |
Why?
| | Outpatients | 1 | 2019 | 366 | 0.120 |
Why?
| | Risk Factors | 3 | 2018 | 9727 | 0.120 |
Why?
| | Surveys and Questionnaires | 6 | 2024 | 5346 | 0.120 |
Why?
| | Pneumothorax | 1 | 1995 | 40 | 0.120 |
Why?
| | Sphingomyelins | 1 | 1995 | 29 | 0.120 |
Why?
| | Phosphatidylglycerols | 1 | 1995 | 24 | 0.120 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 54 | 0.120 |
Why?
| | Infusion Pumps, Implantable | 1 | 2015 | 22 | 0.120 |
Why?
| | Testis | 2 | 2023 | 144 | 0.120 |
Why?
| | Toothbrushing | 1 | 1994 | 6 | 0.120 |
Why?
| | Lung Compliance | 2 | 1995 | 45 | 0.120 |
Why?
| | Attitude to Health | 1 | 1998 | 430 | 0.120 |
Why?
| | Medical Oncology | 1 | 2017 | 272 | 0.120 |
Why?
| | Bulimia | 1 | 1994 | 20 | 0.120 |
Why?
| | Desmin | 2 | 2006 | 24 | 0.120 |
Why?
| | Amniotic Fluid | 1 | 1995 | 86 | 0.120 |
Why?
| | Appendix | 3 | 2001 | 27 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1494 | 0.110 |
Why?
| | Scrotum | 2 | 2007 | 26 | 0.110 |
Why?
| | Bone and Bones | 1 | 1997 | 302 | 0.110 |
Why?
| | Triiodothyronine | 1 | 1994 | 44 | 0.110 |
Why?
| | Sensitivity and Specificity | 3 | 2011 | 1820 | 0.110 |
Why?
| | Laparotomy | 1 | 1994 | 109 | 0.110 |
Why?
| | Organ Size | 2 | 2014 | 440 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2002 | 1883 | 0.110 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 423 | 0.110 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 384 | 0.110 |
Why?
| | Meconium | 1 | 1993 | 7 | 0.110 |
Why?
| | ROC Curve | 2 | 2015 | 501 | 0.110 |
Why?
| | Phenyl Ethers | 1 | 1993 | 4 | 0.110 |
Why?
| | Anastomosis, Surgical | 5 | 2020 | 150 | 0.110 |
Why?
| | Foreign Bodies | 1 | 1994 | 103 | 0.110 |
Why?
| | Foreign-Body Migration | 2 | 2011 | 34 | 0.100 |
Why?
| | Perineum | 2 | 2019 | 26 | 0.100 |
Why?
| | Respiration, Artificial | 1 | 1997 | 594 | 0.100 |
Why?
| | Logistic Models | 1 | 2018 | 1975 | 0.100 |
Why?
| | Apoptosis | 1 | 2002 | 2437 | 0.100 |
Why?
| | Foreskin | 1 | 2012 | 5 | 0.100 |
Why?
| | Nitric Oxide | 2 | 1997 | 886 | 0.100 |
Why?
| | Syndrome | 2 | 2007 | 335 | 0.100 |
Why?
| | Infant Food | 1 | 1993 | 65 | 0.100 |
Why?
| | Fertility | 2 | 2022 | 162 | 0.100 |
Why?
| | Comorbidity | 2 | 2016 | 1540 | 0.100 |
Why?
| | Epispadias | 2 | 2002 | 4 | 0.100 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 194 | 0.100 |
Why?
| | Hydrocortisone | 1 | 1994 | 301 | 0.100 |
Why?
| | Fetal Blood | 1 | 1994 | 313 | 0.100 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 3 | 0.100 |
Why?
| | Shock | 1 | 1993 | 95 | 0.090 |
Why?
| | Metabolism, Inborn Errors | 1 | 2011 | 40 | 0.090 |
Why?
| | Gestational Age | 4 | 2004 | 862 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2736 | 0.090 |
Why?
| | Ovarian Neoplasms | 2 | 2024 | 489 | 0.090 |
Why?
| | Pain Management | 1 | 2013 | 319 | 0.090 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 1936 | 0.090 |
Why?
| | Hernia, Ventral | 1 | 2010 | 23 | 0.080 |
Why?
| | Parents | 1 | 1998 | 1306 | 0.080 |
Why?
| | Ischemia | 1 | 1993 | 395 | 0.080 |
Why?
| | Genetic Therapy | 1 | 2011 | 293 | 0.080 |
Why?
| | Databases, Factual | 3 | 2019 | 1268 | 0.080 |
Why?
| | Acute Disease | 1 | 2012 | 968 | 0.080 |
Why?
| | Urinary Reservoirs, Continent | 2 | 2016 | 4 | 0.080 |
Why?
| | Intestines | 3 | 2020 | 345 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 571 | 0.080 |
Why?
| | Campomelic Dysplasia | 1 | 2009 | 2 | 0.080 |
Why?
| | Dysgerminoma | 1 | 2009 | 6 | 0.080 |
Why?
| | BK Virus | 1 | 2009 | 13 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1669 | 0.080 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 229 | 0.080 |
Why?
| | Urolithiasis | 1 | 2009 | 9 | 0.080 |
Why?
| | Polyomavirus Infections | 1 | 2009 | 27 | 0.080 |
Why?
| | SOX9 Transcription Factor | 1 | 2009 | 24 | 0.080 |
Why?
| | Tumor Virus Infections | 1 | 2009 | 45 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 1 | 2009 | 40 | 0.080 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 1997 | 626 | 0.080 |
Why?
| | Cohort Studies | 2 | 2016 | 5369 | 0.070 |
Why?
| | Ureterostomy | 1 | 2007 | 3 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 268 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2603 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 717 | 0.070 |
Why?
| | Nanoparticles | 1 | 2011 | 368 | 0.070 |
Why?
| | Urogenital Neoplasms | 1 | 2006 | 5 | 0.070 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 144 | 0.070 |
Why?
| | Myogenin | 1 | 2006 | 13 | 0.070 |
Why?
| | Calcinosis | 1 | 2009 | 231 | 0.070 |
Why?
| | Pulmonary Artery | 4 | 1997 | 1028 | 0.070 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2006 | 20 | 0.070 |
Why?
| | Neoplasms | 1 | 2021 | 2465 | 0.070 |
Why?
| | Liver Neoplasms | 1 | 2011 | 640 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2009 | 1271 | 0.060 |
Why?
| | Hematocolpos | 1 | 2005 | 3 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 240 | 0.060 |
Why?
| | Fetal Organ Maturity | 2 | 1995 | 27 | 0.060 |
Why?
| | Malabsorption Syndromes | 1 | 2004 | 16 | 0.060 |
Why?
| | Defecation | 1 | 2004 | 19 | 0.060 |
Why?
| | Gonadoblastoma | 1 | 2024 | 6 | 0.060 |
Why?
| | Nutritional Support | 1 | 2004 | 31 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1490 | 0.060 |
Why?
| | Menstruation Disturbances | 1 | 2003 | 12 | 0.050 |
Why?
| | Salvage Therapy | 1 | 2004 | 137 | 0.050 |
Why?
| | Coitus | 1 | 2003 | 25 | 0.050 |
Why?
| | Rabbits | 2 | 1996 | 761 | 0.050 |
Why?
| | Urologists | 1 | 2023 | 17 | 0.050 |
Why?
| | Steroid 21-Hydroxylase | 1 | 2003 | 30 | 0.050 |
Why?
| | Decision Support Techniques | 1 | 2007 | 398 | 0.050 |
Why?
| | Urethral Obstruction | 1 | 2003 | 9 | 0.050 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 17 | 0.050 |
Why?
| | Methyl Green | 1 | 2003 | 1 | 0.050 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2003 | 8 | 0.050 |
Why?
| | Colostomy | 3 | 2004 | 26 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 3881 | 0.050 |
Why?
| | Mast Cells | 1 | 2024 | 142 | 0.050 |
Why?
| | Urine | 1 | 2003 | 54 | 0.050 |
Why?
| | Ascites | 1 | 2003 | 43 | 0.050 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2024 | 186 | 0.050 |
Why?
| | Azo Compounds | 1 | 2003 | 26 | 0.050 |
Why?
| | Urothelium | 1 | 2003 | 37 | 0.050 |
Why?
| | Urinary Sphincter, Artificial | 1 | 2002 | 3 | 0.050 |
Why?
| | Erectile Dysfunction | 1 | 2022 | 39 | 0.050 |
Why?
| | Mandelic Acids | 1 | 2002 | 2 | 0.050 |
Why?
| | Pain Threshold | 1 | 2002 | 72 | 0.050 |
Why?
| | Endocrinology | 1 | 2003 | 74 | 0.050 |
Why?
| | Puberty | 1 | 2003 | 143 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2007 | 301 | 0.050 |
Why?
| | Observer Variation | 1 | 2003 | 315 | 0.050 |
Why?
| | Pelvic Neoplasms | 1 | 2002 | 19 | 0.050 |
Why?
| | Mucous Membrane | 1 | 2003 | 120 | 0.050 |
Why?
| | Oligohydramnios | 1 | 2002 | 11 | 0.050 |
Why?
| | Cholinergic Antagonists | 1 | 2002 | 29 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2002 | 50 | 0.050 |
Why?
| | Dilatation, Pathologic | 2 | 2001 | 61 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3023 | 0.050 |
Why?
| | Ureteral Diseases | 1 | 2001 | 3 | 0.050 |
Why?
| | Blood Pressure | 4 | 1997 | 1733 | 0.050 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 9 | 0.050 |
Why?
| | Proteolipids | 2 | 2000 | 30 | 0.050 |
Why?
| | Learning Curve | 1 | 2022 | 66 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2002 | 215 | 0.050 |
Why?
| | Cysts | 1 | 2002 | 108 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 2007 | 888 | 0.040 |
Why?
| | Urinary Fistula | 1 | 2000 | 9 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 430 | 0.040 |
Why?
| | Radiography | 1 | 2003 | 864 | 0.040 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2000 | 34 | 0.040 |
Why?
| | Blotting, Western | 1 | 2003 | 1168 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2521 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2023 | 860 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2024 | 1943 | 0.040 |
Why?
| | Jejunal Diseases | 1 | 1999 | 7 | 0.040 |
Why?
| | Gastric Fistula | 1 | 1999 | 9 | 0.040 |
Why?
| | Intestinal Fistula | 1 | 1999 | 15 | 0.040 |
Why?
| | Actins | 1 | 2002 | 401 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 9 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2019 | 8 | 0.040 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2019 | 20 | 0.040 |
Why?
| | Middle Aged | 6 | 2024 | 30893 | 0.040 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 75 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 359 | 0.040 |
Why?
| | Pulmonary Alveoli | 2 | 2000 | 366 | 0.040 |
Why?
| | Digestive System Diseases | 1 | 1998 | 25 | 0.040 |
Why?
| | Pelvis | 1 | 1999 | 102 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 20 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 21 | 0.040 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 27 | 0.040 |
Why?
| | Counseling | 1 | 2002 | 386 | 0.040 |
Why?
| | Cecostomy | 1 | 1998 | 3 | 0.040 |
Why?
| | Surgical Stomas | 1 | 1998 | 7 | 0.040 |
Why?
| | Drainage | 1 | 1999 | 165 | 0.040 |
Why?
| | Surgical Mesh | 1 | 1998 | 46 | 0.040 |
Why?
| | Quality of Life | 1 | 2009 | 2680 | 0.040 |
Why?
| | Mutation | 1 | 2009 | 3692 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2003 | 727 | 0.040 |
Why?
| | Sigmoid Diseases | 1 | 1997 | 10 | 0.040 |
Why?
| | Capillaries | 1 | 1998 | 92 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 1997 | 71 | 0.040 |
Why?
| | Survival Analysis | 2 | 2017 | 1265 | 0.030 |
Why?
| | Cardiology Service, Hospital | 1 | 1997 | 27 | 0.030 |
Why?
| | Ileal Diseases | 1 | 1996 | 13 | 0.030 |
Why?
| | Ampulla of Vater | 1 | 1997 | 38 | 0.030 |
Why?
| | Duodenum | 1 | 1997 | 71 | 0.030 |
Why?
| | Rhabdomyosarcoma | 1 | 2017 | 64 | 0.030 |
Why?
| | Stomach | 1 | 1997 | 109 | 0.030 |
Why?
| | Rats | 2 | 1996 | 5168 | 0.030 |
Why?
| | Barrett Esophagus | 1 | 1999 | 144 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 103 | 0.030 |
Why?
| | Rectal Neoplasms | 2 | 1998 | 136 | 0.030 |
Why?
| | Collagen | 2 | 1995 | 429 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1229 | 0.030 |
Why?
| | Umbilical Cord | 1 | 1996 | 84 | 0.030 |
Why?
| | Persistent Fetal Circulation Syndrome | 2 | 1995 | 136 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5040 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 121 | 0.030 |
Why?
| | Clinical Protocols | 1 | 1997 | 253 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 656 | 0.030 |
Why?
| | Wound Healing | 1 | 1998 | 310 | 0.030 |
Why?
| | NADPH Dehydrogenase | 1 | 1995 | 8 | 0.030 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 18 | 0.030 |
Why?
| | Tunica Intima | 1 | 1995 | 82 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1681 | 0.030 |
Why?
| | Proteins | 3 | 1995 | 936 | 0.030 |
Why?
| | United States | 1 | 2011 | 13876 | 0.030 |
Why?
| | Swine | 1 | 1996 | 743 | 0.030 |
Why?
| | Bupivacaine | 1 | 1994 | 30 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 33 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7040 | 0.030 |
Why?
| | Thoracotomy | 1 | 1994 | 74 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 579 | 0.030 |
Why?
| | Endothelins | 1 | 1994 | 59 | 0.030 |
Why?
| | Heart Diseases | 1 | 1997 | 345 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 728 | 0.030 |
Why?
| | Sigmoid Neoplasms | 1 | 1993 | 3 | 0.030 |
Why?
| | Disease Management | 1 | 2017 | 588 | 0.030 |
Why?
| | Hypertonic Solutions | 1 | 1993 | 7 | 0.030 |
Why?
| | Product Labeling | 1 | 1993 | 6 | 0.030 |
Why?
| | Gangrene | 1 | 1993 | 10 | 0.030 |
Why?
| | Ileostomy | 2 | 2004 | 20 | 0.030 |
Why?
| | Recurrence | 1 | 1995 | 1001 | 0.020 |
Why?
| | INDEL Mutation | 1 | 2011 | 15 | 0.020 |
Why?
| | Necrosis | 1 | 1993 | 231 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2011 | 31 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 1997 | 492 | 0.020 |
Why?
| | Consanguinity | 1 | 2011 | 47 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 149 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2011 | 75 | 0.020 |
Why?
| | Colorado | 2 | 2018 | 4392 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 345 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 161 | 0.020 |
Why?
| | Colitis | 1 | 1993 | 240 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2000 | 280 | 0.020 |
Why?
| | Aged | 3 | 2024 | 21971 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2013 | 644 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1995 | 736 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2134 | 0.020 |
Why?
| | Tissue Survival | 1 | 2007 | 16 | 0.020 |
Why?
| | Chronic Disease | 1 | 1993 | 1701 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 38 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 136 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 94 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 172 | 0.020 |
Why?
| | Microsurgery | 1 | 2007 | 69 | 0.020 |
Why?
| | Vaginal Neoplasms | 1 | 2006 | 12 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 1998 | 1735 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1481 | 0.020 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2006 | 65 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2009 | 1209 | 0.020 |
Why?
| | Hydroxyproline | 2 | 1995 | 22 | 0.020 |
Why?
| | Elastin | 2 | 1995 | 78 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2011 | 2752 | 0.010 |
Why?
| | Duodenal Obstruction | 1 | 2004 | 4 | 0.010 |
Why?
| | Intestinal Atresia | 1 | 2004 | 14 | 0.010 |
Why?
| | Parenteral Nutrition, Total | 1 | 2004 | 27 | 0.010 |
Why?
| | Short Bowel Syndrome | 1 | 2004 | 26 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3160 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1416 | 0.010 |
Why?
| | Enteritis | 1 | 2004 | 94 | 0.010 |
Why?
| | Gender Identity | 1 | 2003 | 122 | 0.010 |
Why?
| | Europe | 1 | 2003 | 362 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1141 | 0.010 |
Why?
| | Aorta | 2 | 1995 | 407 | 0.010 |
Why?
| | Abdomen | 1 | 2002 | 116 | 0.010 |
Why?
| | Hip Joint | 1 | 2002 | 157 | 0.010 |
Why?
| | Movement | 1 | 2002 | 267 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 931 | 0.010 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2000 | 101 | 0.010 |
Why?
| | Societies, Medical | 1 | 2003 | 749 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 1010 | 0.010 |
Why?
| | Glycoproteins | 1 | 2000 | 337 | 0.010 |
Why?
| | Compartment Syndromes | 1 | 1998 | 31 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4008 | 0.010 |
Why?
| | DNA | 2 | 1995 | 1392 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 503 | 0.010 |
Why?
| | Blood-Air Barrier | 1 | 1998 | 10 | 0.010 |
Why?
| | Leiomyoma | 1 | 1998 | 74 | 0.010 |
Why?
| | Survival Rate | 1 | 2002 | 1872 | 0.010 |
Why?
| | Skin | 1 | 2002 | 717 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 184 | 0.010 |
Why?
| | Esophagoscopy | 1 | 1999 | 195 | 0.010 |
Why?
| | Venous Thrombosis | 1 | 1998 | 158 | 0.010 |
Why?
| | Constriction | 1 | 1996 | 42 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2002 | 535 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1996 | 55 | 0.010 |
Why?
| | Hospitals, Veterans | 1 | 1997 | 257 | 0.010 |
Why?
| | Venules | 1 | 1995 | 15 | 0.010 |
Why?
| | Heart Septum | 1 | 1995 | 26 | 0.010 |
Why?
| | Arterioles | 1 | 1995 | 40 | 0.010 |
Why?
| | Biopsy | 1 | 1999 | 1085 | 0.010 |
Why?
| | Heart Septal Defects, Atrial | 1 | 1995 | 46 | 0.010 |
Why?
| | Pneumonia | 1 | 2000 | 599 | 0.010 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1995 | 49 | 0.010 |
Why?
| | Heart Atria | 1 | 1995 | 124 | 0.010 |
Why?
| | Pleura | 1 | 1994 | 21 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 1995 | 232 | 0.010 |
Why?
| | Bronchi | 1 | 1995 | 240 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 732 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1995 | 538 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 1995 | 664 | 0.010 |
Why?
| | Hospital Mortality | 1 | 1997 | 844 | 0.010 |
Why?
| | Heparin | 1 | 1994 | 240 | 0.010 |
Why?
| | Echocardiography | 1 | 1994 | 625 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1995 | 766 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1999 | 1057 | 0.010 |
Why?
|
|
Wilcox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|